204 related articles for article (PubMed ID: 6443011)
1. [Benznidazole and chronic Chagas disease].
Manigot DA
Medicina (B Aires); 1984; 44(1):105-6. PubMed ID: 6443011
[No Abstract] [Full Text] [Related]
2. [Treatment of chronic Chagas' disease. Is the etiological treatment effective?].
Rassi A; Rassi Júnior A
Arq Bras Cardiol; 1998 Oct; 71(4):643-6. PubMed ID: 10347944
[No Abstract] [Full Text] [Related]
3. Should benznidazole be used in chronic Chagas' disease?
Bestetti RB
Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
[No Abstract] [Full Text] [Related]
4. Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.
Bustamante JM; Presti MS; Rivarola HW; Fernández AR; Enders JE; Fretes RE; Paglini-Oliva P
Int J Antimicrob Agents; 2007 Jun; 29(6):733-7. PubMed ID: 17395432
[TBL] [Abstract][Full Text] [Related]
5. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
[TBL] [Abstract][Full Text] [Related]
6. [Benzonidazole: one of the rare treatment for Chagas disease].
Coilliot C; Rouault M; Wolf A; Boulliat C; Beranger C; Gaillard K; Oliver M
Med Trop (Mars); 2011 Feb; 71(1):25-7. PubMed ID: 21585085
[TBL] [Abstract][Full Text] [Related]
7. [Allopurinol in the treatment of chronic Chagas' disease].
Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
[No Abstract] [Full Text] [Related]
8. Difference of effective antitrypanosomal dosages of benznidazole in mice and man. Chemotherapeutic and pharmacokinetic results.
Richle RW; Raaflaub J
Acta Trop; 1980 Sep; 37(3):257-61. PubMed ID: 6106364
[No Abstract] [Full Text] [Related]
9. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
[No Abstract] [Full Text] [Related]
10. [Clinico-therapeutic trial with benzonidazole in Chagas' disease].
Ferreira HD
Rev Inst Med Trop Sao Paulo; 1976; 18(5):357-64. PubMed ID: 827007
[No Abstract] [Full Text] [Related]
11. An update on benznidazole for the treatment of patients with Chagas disease.
Thakare R; Dasgupta A; Chopra S
Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
[TBL] [Abstract][Full Text] [Related]
12. Long term evaluation of etiological treatment of chagas disease with benznidazole.
Cancado JR
Rev Inst Med Trop Sao Paulo; 2002; 44(1):29-37. PubMed ID: 11896410
[TBL] [Abstract][Full Text] [Related]
13. Clinical and serological evolution in chronic Chagas disease patients in a 4-year pharmacotherapy follow-up: a preliminary study.
Andrade MC; Oliveira Mde F; Nagao-Dias AT; Coêlho IC; Cândido Dda S; Freitas EC; Coelho HL; Bezerra FS
Rev Soc Bras Med Trop; 2013; 46(6):776-8. PubMed ID: 24474023
[TBL] [Abstract][Full Text] [Related]
14. The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease.
Ghobadifar MA; Kalani N; Gitiforouz M; Mosallanejad Z
Rev Soc Bras Med Trop; 2014; 47(5):669. PubMed ID: 25467275
[No Abstract] [Full Text] [Related]
15. Treatment of experimental chronic chagas disease with trifluralin.
Zaidenberg A; Luong T; Lirussi D; Bleiz J; Del Buono MB; Quijano G; Drut R; Kozubsky L; Marron A; Buschiazzo H
Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):351-6. PubMed ID: 16623857
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy with Benznidazole and repurposed drugs Clofazimine and Benidipine for chronic Chagas disease.
Sbaraglini ML; Bellera CL; Quarroz Braghini J; Areco Y; Miranda C; Carrillo C; Kelly J; Buchholz B; Gelpi RJ; Talevi A; Alba Soto CD
Eur J Med Chem; 2019 Dec; 184():111778. PubMed ID: 31630056
[No Abstract] [Full Text] [Related]
17. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country.
Carrilero B; Murcia L; Martínez-Lage L; Segovia M
Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093
[TBL] [Abstract][Full Text] [Related]
18. Chagas seropositive donors in kidney transplantation.
Sousa AA; Lobo MC; Barbosa RA; Bello V
Transplant Proc; 2004 May; 36(4):868-9. PubMed ID: 15194296
[TBL] [Abstract][Full Text] [Related]
19. Summaries for patients. Long-term outcomes of treating nonacute Chagas disease with benznidazole.
Ann Intern Med; 2006 May; 144(10):I32. PubMed ID: 16702585
[No Abstract] [Full Text] [Related]
20. The need of a neonatal preparation for Chagas disease.
Sosa-Estani S; Belizan JM; Althabe F; Rubinstein A
PLoS Med; 2005 Nov; 2(11):e387. PubMed ID: 16288560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
